7-Amino-4-Boc-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 500mg

3-METHYL-4,5,6,7-TETRAHYDRO-2H-INDAZOLE-5-CARBOXYLIC ACID, 95.0%, 250mg

7-Bromo-1-chloronaphthalene, 97%, 100mg

2-hydroxy-4-methyl-6-quinolinesulfonyl chloride, 95.0%, 250mg

2-PIVALYLAMINO-PYRIDINE-3-CARBOXYALDEHYDE, 97.0%, 10g

Benzyl (S)-2-(cyanomethyl)piperazine-1-carboxylate, 97%, 5g

(2S,3S,4R,5R)-2,3,4,5-tetrahydroxyhexanal, 98%, 100mg

ethyl 7-bromo-1-benzothiophene-2-carboxylate, 1g

Pentaerythritol, min. 98%, for synthesis, 500 g, plastic packaging.

Potassium iodate, min. 99.4%, pa, ACS, 250 g, plastic packaging.

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 100, 1000 ml, 130 mm, 1 Piece

4-amino-3-(3-methoxyphenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 100mg

2-(4-Chloro-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g